Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Licenses Novici's ErrAse Technology for DNA-error Correction

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced a licensing agreement for Novici Biotech's technology for DNA-error correction as part of its continued expansion into the synthetic biology space.

Under the terms of the deal, Life Tech will integrate Novici's ErrAse DNA-error correction kit into its synthetic biology offerings and retain all rights to sublicense the technology. ErrAse will be available for research purposes through Novici until it is launched with the Life Tech name.

ErrAse is an enzymatic technology. By detecting and correcting mismatched based pairs introduced by short DNA synthesis or during PCR assembly, the technology can "dramatically" reduce errors in synthetic gene sequences, Life Tech said in a statement. It added that the technology allows for larger, more accurate DNA sequences, "saving researchers time and cost associated with inaccuracies in the gene synthesis process."

Financial terms of the deal were not disclosed.

The agreement is the most recent move by Life Tech as part of its strategy to increase its footprint in the synthetic biology market. Citing statistics from BCC Research, the company said that the space is estimated to reach $2.4 billion by 2013.

In May, Life Tech acquired a majority stake in synthetic gene firm Geneart for $47 million, and a month later it made an investment into Synthetic Genomics of $10 million, according to a document filed with the US Securities and Exchange Commission.

Soon after, a company official told GenomeWeb Daily News that "we see synthetic biology as a great long-term opportunity to really impact the world with solutions based on biology."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.